Valuation ResMed Inc. Australian S.E.
Stocks
RMD
AU000000RMD6
Advanced Medical Equipment & Technology
|
Market Closed -
Australian S.E.
02:11:20 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 30.74 AUD | -2.13% |
|
-7.38% | -14.47% |
Company Valuation: ResMed Inc.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30,691 | 32,133 | 28,117 | 37,762 | 28,145 | 31,624 | - | - |
| Change | - | 4.7% | -12.5% | 34.31% | -25.47% | 12.36% | - | - |
| Enterprise Value (EV) 1 | 31,192 | 33,346 | 28,585 | 37,221 | 27,335 | 30,670 | 29,931 | 29,136 |
| Change | - | 6.9% | -14.28% | 30.21% | -26.56% | 12.2% | -2.41% | -2.65% |
| P/E | 39.6x | 35.9x | 27.7x | 27.1x | 18.7x | 18.9x | 17.2x | 15.8x |
| PBR | 9.35x | 7.76x | 5.78x | 6.33x | - | 4.55x | 4.09x | 4.19x |
| PEG | - | 2.4x | 2x | 0.7x | 1.93x | 1.6x | 1.78x | 1.82x |
| Capitalization / Revenue | 8.58x | 7.61x | 6x | 7.34x | 4.98x | 5.44x | 5.11x | 4.79x |
| EV / Revenue | 8.72x | 7.9x | 6.1x | 7.23x | 4.84x | 5.28x | 4.84x | 4.42x |
| EV / EBITDA | 26.8x | 25.3x | 18.1x | 19.8x | 11.7x | 13.6x | 12.4x | 11.3x |
| EV / EBIT | 31.2x | 27.2x | 19.3x | 21.1x | 13.4x | 14.7x | 13.2x | 12x |
| EV / FCF | 144x | 58.1x | 22x | 22.4x | 16.6x | 18.7x | 16.9x | 15.3x |
| FCF Yield | 0.69% | 1.72% | 4.55% | 4.46% | 6.03% | 5.36% | 5.91% | 6.54% |
| Dividend per Share 2 | 1.68 | 1.8 | 1.92 | 2.12 | 2.46 | 2.66 | 2.929 | 3.198 |
| Rate of return | 0.8% | 0.82% | 1% | 0.82% | 1.26% | 1.21% | 1.33% | 1.45% |
| EPS 2 | 5.3 | 6.09 | 6.92 | 9.51 | 10.43 | 11.67 | 12.79 | 13.9 |
| Distribution rate | 31.7% | 29.6% | 27.7% | 22.3% | 23.6% | 22.8% | 22.9% | 23% |
| Net sales 1 | 3,578 | 4,223 | 4,685 | 5,146 | 5,653 | 5,811 | 6,189 | 6,599 |
| EBITDA 1 | 1,162 | 1,317 | 1,576 | 1,884 | 2,329 | 2,251 | 2,421 | 2,581 |
| EBIT 1 | 1,000 | 1,224 | 1,478 | 1,763 | 2,039 | 2,092 | 2,262 | 2,421 |
| Net income 1 | 779.4 | 897.6 | 1,021 | 1,401 | 1,523 | 1,643 | 1,782 | 1,916 |
| Net Debt 1 | 501.5 | 1,213 | 468.9 | -541.2 | -809.9 | -954.4 | -1,693 | -2,488 |
| Reference price 2 | 209.63 | 218.50 | 191.42 | 258.00 | 194.88 | 219.95 | 219.95 | 219.95 |
| Nbr of stocks (in thousands) | 146,405 | 147,062 | 146,884 | 146,365 | 144,421 | 143,062 | - | - |
| Announcement Date | 8/11/22 | 8/3/23 | 8/1/24 | 7/31/25 | 8/6/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 29.97x | 5.32x | 20.4x | 0.31% | 223B | ||
| 34.62x | 6.25x | 19.82x | 0.69% | 144B | ||
| 37.95x | 9.97x | 21.99x | -.--% | 124B | ||
| 16.79x | 3.46x | 11.22x | -.--% | 65.19B | ||
| 34.27x | 6.86x | 21.69x | -.--% | 49.99B | ||
| 19.37x | 2.33x | 11.69x | 2.63% | 50.49B | ||
| 28.6x | 5.65x | 19.18x | 0.7% | 41.4B | ||
| 70.54x | 6.74x | 20.53x | -.--% | 39.59B | ||
| 42.67x | 6.94x | 24.5x | -.--% | 31.87B | ||
| Average | 34.98x | 5.95x | 19.00x | 0.48% | 85.5B | |
| Weighted average by Cap. | 33.13x | 6.15x | 19.39x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RMD Stock
- RMD Stock
- Valuation ResMed Inc.
Select your edition
All financial news and data tailored to specific country editions
















